ASN
BMY.RT

Advisory Services Network’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Advisory Services Network’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,381
Closed -$4K – 3338
2020
Q4 		$4K Sell
6,381
-5,338
-46% -$11.4K ﹤0.01% 2837
2020
Q3 		$26K Sell
11,719
-4,128
-26% -$11.8K ﹤0.01% 1954
2020
Q2 		$57K Buy
+15,847
New +$57.2K ﹤0.01% 1020

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Advisory Services Network's BMY.RT Position: Q1 2021 in Review

Advisory Services Network sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 6,381 shares — an estimated $4K sold.

Advisory Services Network first reported a position in BMY.RT in Q2 2020 and held it in 3 quarters. The position peaked at $57K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Advisory Services Network reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Advisory Services Network sold 6,381 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $4K.
  • Advisory Services Network first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 3 quarters.
  • Advisory Services Network's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $57K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.